Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Euclid Vision is a global leader in myopia management and advanced specialty contact lens technology, primarily known for its expertise in orthokeratology (Ortho-K). The company designs and manufactures high-performance gas permeable lenses, including the flagship Euclid Emerald and Euclid MAX, which are used to temporarily reshape the cornea overnight to correct vision and slow the progression of myopia in pediatric patients. Through its Euclid Vision Group platform, the company integrates multiple specialty lens brands to provide comprehensive solutions for eye care professionals. Euclid maintains a significant international presence, particularly in the United States and China, and is one of the few companies with FDA-approved overnight Ortho-K designs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Euclid Vision.